TrialThe New England journal of medicine2008
Aliskiren combined with losartan in type 2 diabetes and nephropathy.
Hans-Henrik Parving et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
320 papers cite itlatest 60 shown
this paperpooled ittrialcites it